Categories Analysis, Retail

Here are a few points to consider if you have Macy’s (M) on your mind

For the second quarter of 2022, the company expects net sales of $5.5-5.6 billion and adjusted EPS of $0.84-0.94

Shares of Macy’s Inc. (NYSE: M) stayed in red territory on Wednesday. The stock has gained 24% over the past 12 months. Last week, the company delivered strong results for the first quarter of 2022 and raised its guidance for the full year. There is a bullish sentiment around this stock and here are a few points to keep in mind if you are considering it:

Sales growth

Macy’s generated net sales of $5.3 billion in Q1 2022, reflecting a year-over-year growth of over 13%, despite facing inflationary pressures and other macroeconomic headwinds. Comparable sales increased 12.8% on an owned basis and 12.4% on an owned-plus-licensed basis.

Comp sales for the Macy’s brand were up 10.1% on an owned plus licensed basis. The retailer witnessed shifts in shopping patterns during the quarter as customers ditched digital shopping in favor of returning to stores. There was also a higher preference for occasion-based apparel like dresses and women’s shoes over the pandemic-favorite categories like casualwear and active wear.

Macy's Q1 2022 Earnings Infographic

Despite a slowdown from the previous quarter, digital sales rose 2% compared to 2021 and 34% compared to 2019. More than 88% of the company’s omnichannel markets witnessed sales growth during the quarter.

Profitability and margins

Macy’s delivered adjusted EPS of $1.08 in Q1, which was almost three times higher than the $0.39 reported in the year-ago period. The bottom line performance was driven by higher gross margins and disciplined expense management.

Adjusted EBITDA margin rose 270 basis points YoY to 12.8%. Gross margin during the quarter increased 100 basis points YoY to 39.6%. Merchandise margin rose 50 basis points, benefiting from higher average unit retail which was in turn driven by lower promotions on regular price merchandise, higher ticket prices and category mix.


Macy’s reaffirmed its sales guidance and raised its earnings guidance for the full year of 2022. The company believes its outlook reflects the risks associated with the ongoing macroeconomic uncertainty. The retailer expects net sales to range between $24.4-24.7 billion, which reflects a growth of flat to up 1% YoY.

Digital sales, as a percent of net sales, are expected to be approx. 35%, down from the previous estimate of 37%. The reduction in digital penetration is due to the shift from digital to in-store shopping as well as the shift to occasion-based apparel, which has a higher return rate than categories like home and beauty.

Adjusted EBITDA as a percent of sales is expected to be 11.2-11.7% in FY2022. Macy’s raised its adjusted EPS guidance to a range of $4.53-4.95 from the previous range of $4.13-4.52. For the second quarter of 2022, the company expects net sales of $5.5-5.6 billion and adjusted EPS of $0.84-0.94.

Click here to read more on retail stocks

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Viewing Highlight